COVID-19: Vaccines and Therapeutics
Ochsner Health’s Innovation Health Podcast series provides in-depth vaccine discussions to address safety concerns among minority groups.
When Cheryl Owens saw the growing skepticism about the COVID-19 vaccines among African Americans in the city of Tuskegee, Ala., where she was born and raised, she decided to get involved.
Photo Credit: Southwest Health System
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended Pfizer’s COVID-19 vaccine for administration in adolescents ages 12 to 15.
The Federal Emergency Management Agency is reminding stakeholders that funding is available under FEMA’s Public Assistance program, including for community engagement and information dissemination to promote vaccination availability, scheduling, and accessibility, as well as reimbursement for…
The Centers for Medicare & Medicaid Services released an interim final rule requiring long-term care facilities in the Medicare and Medicaid programs to offer the COVID-19 vaccine to residents and staff, educate them on the benefits and potential side effects, and begin reporting weekly COVID-…
The Food and Drug Administration announced the expansion of its emergency use authorization for Pfizer’s COVID-19 vaccine to include adolescents ages 12 to 15.
Illinois health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence in Illinois of the SARS-CoV-2 P.1 variant, which is not susceptible to the combination therapy, the Office of the Assistant Secretary for…
AtlantiCare relies on efficient and effective collaboration and communication to vaccinate communities.
A team of doctors and scientists at UVA Health answers the public’s questions about deployment, efficacy and safety of all COVID-19 vaccines.